By the Editorial BoardBozeman (Mont.) Daily Chronicle, Sept. 23, 2016When Blue Cross and Blue Shield of Montana recently pared back its planned health insurance premium
Big Pharma execs are the new robber barons
By F. Douglas StephensonThe Gainesville (Fla.) Sun, Sept. 18, 2016Mylan Pharmaceuticals has been price gouging its life-saving injectable epinephrine — EpiPen — by charging $300
Oregon can pave the way for a single-payer system
Patient-centered, high-quality health care accessible to all is a realistic vision, says Dr. Paul GormanBy Paul Gorman, M.D.Portland (Ore.) Business Journal, Sept. 15, 2016Every person
Insurers May Be Down on the ACA’s Exchanges …
This article includes video... but they should be careful what they wish forBy Caroline Poplin, M.D., J.D.MedPage Today, Sept. 6, 2016By Carol Poplin, M.D., J.D. | MedPage Today,
Studies Show Veterans Health Care Improving
By Suzanne GordonThe American Prospect, Tapped Blog, Aug. 16, 2016When the House Veterans Affairs Committee holds a hearing on September 7 to assess the future
Socialize the EpiPen
The EpiPen mess shows that we need drugs that function as real social goods, not rent-producing commoditiesBy Adam Gaffney, M.D.Jacobin, Sept. 2, 2016The ongoing EpiPen
Single-payer model is the only answer to outrageous price hikes
By Robert RosofskyThe Boston Globe, Letters, Aug. 31, 2016As both an EpiPen carrier and a public health informatics consultant, I closely follow facts and opinions
Assessing the ACA in the Political Fog
By Steffie Woolhandler, M.D., M.P.H., Adam Gaffney, M.D., and David Himmelstein, M.D.MedPage Today, Aug. 26, 2016In the current overheated political climate, the Affordable Care Act
The Sticking Points in Obamacare
By Elizabeth R. Rosenthal, M.D.The New York Times, Letters, Aug. 25, 2016Re “U.S. Prepares Enrollment Push as Insurers Balk on Health Law” (front page, Aug.
Americans deserve better than choosing among crummy insurance plans
By Ed Weisbart, M.D.St. Louis Post-Dispatch, Letters, Aug. 26, 2016When I read that Aetna was pulling out of the Missouri health insurance marketplace, I immediately
Why Mylan’s Alleged Solution to Its EpiPen Price-Gouging Scandal Is a Scam
The only solution for expanding access to the life-saving EpiPen is to reduce the priceBy Sarah LazareAlterNet, Aug. 25, 2016The pharmaceutical giant Mylan has a
The tyranny of corporatized health care: Time for single payer
By Craig Klugman, Ph.D.Bioethics.net Blog, Aug. 24, 2016In Illinois, Land of Lincoln insurance and Aetna announced that they are pulling out of the health insurance